药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tazarotene
Moxonidine
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Moxonidine.
Tazarotene
Indoramin
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Indoramin.
Tazarotene
Irbesartan
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Irbesartan.
Tazarotene
Pipamperone
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Pipamperone.
Tazarotene
Fimasartan
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Fimasartan.
Tazarotene
Nitrous acid
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Nitrous acid.
Tazarotene
Isoxsuprine
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Isoxsuprine.
Tazarotene
Azilsartan medoxomil
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Azilsartan medoxomil.
Tazarotene
Nesiritide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Nesiritide.
Tazarotene
Amyl Nitrite
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Amyl Nitrite.
Tazarotene
Carbetocin
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Carbetocin.
Tazarotene
Amifostine
The risk or severity of adverse effects can be increased when Amifostine is combined with Arsenic trioxide.
Tazarotene
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Arsenic trioxide.
Tazarotene
Berotralstat
The risk or severity of QTc prolongation can be increased when Berotralstat is combined with Arsenic trioxide.
Tazarotene
Emedastine
The risk or severity of QTc prolongation can be increased when Emedastine is combined with Arsenic trioxide.
Tazarotene
Encorafenib
The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Arsenic trioxide.
Tazarotene
Levacetylmethadol
The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Arsenic trioxide.
Tazarotene
Quetiapine
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Quetiapine.
Tazarotene
Clomipramine
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Clomipramine.
Tazarotene
Saquinavir
The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Arsenic trioxide.